Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies.

Journal: Cancer research
Published Date:

Abstract

UNLABELLED: Bone marrow trephine biopsy is crucial for the diagnosis of multiple myeloma. However, the complexity of bone marrow cellular, morphologic, and spatial architecture preserved in trephine samples hinders comprehensive evaluation. To dissect the diverse cellular communities and mosaic tissue habitats, we developed a superpixel-inspired deep learning method (MoSaicNet) that adapts to complex tissue architectures and a cell imbalance aware deep learning pipeline (AwareNet) to enable accurate detection and classification of rare cell types in multiplex immunohistochemistry images. MoSaicNet and AwareNet achieved an AUC of >0.98 for tissue and cellular classification on separate test datasets. Application of MoSaicNet and AwareNet enabled investigation of bone heterogeneity and thickness as well as spatial histology analysis of bone marrow trephine samples from monoclonal gammopathies of undetermined significance (MGUS) and from paired newly diagnosed and posttreatment multiple myeloma. The most significant difference between MGUS and newly diagnosed multiple myeloma (NDMM) samples was not related to cell density but to spatial heterogeneity, with reduced spatial proximity of BLIMP1+ tumor cells to CD8+ cells in MGUS compared with NDMM samples. Following treatment of patients with multiple myeloma, there was a reduction in the density of BLIMP1+ tumor cells, effector CD8+ T cells, and regulatory T cells, indicative of an altered immune microenvironment. Finally, bone heterogeneity decreased following treatment of patients with multiple myeloma. In summary, deep learning-based spatial mapping of bone marrow trephine biopsies can provide insights into the cellular topography of the myeloma marrow microenvironment and complement aspirate-based techniques.

Authors

  • Yeman Brhane Hagos
    Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Catherine S Y Lecat
    Research Department of Hematology, Cancer Institute, University College London, UK.
  • Dominic Patel
    Research Department of Hematology, Cancer Institute, University College London, UK.
  • Anna Mikolajczak
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Simon P Castillo
    Centre for Evolution and Cancer and Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
  • Emma J Lyon
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Kane Foster
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Thien-An Tran
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Lydia S H Lee
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Manuel Rodriguez-Justo
    Research Department of Pathology, University College London, London, United Kingdom.
  • Kwee L Yong
    Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
  • Yinyin Yuan
    Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address: yyuan6@mdanderson.org.